Home
Rigshospitalet

Post Docs

Contact

Violette Richin
Position:
Post Doc
Dept. Neurology and Neurobiology Research Unit,
Copenhagen University Hospital, Rigshospitalet,
Building 8057,
Blegdamsvej 9, DK-2100 Copenhagen, Denmark
This email address is being protected from spambots. You need JavaScript enabled to view it.
3545 6714

Curriculum vitae

Curriculum vitae

Scientific interests

Violette is interested in the development of new imaging tools for neuropsychopharmacology. During her PhD, she developed several PET radiotracers for imaging serotonin receptors (5-HT2B and 5-HT1A). As a postdoctoral researcher at NRU, she is now focusing on the development of new radiotracers to image TrkB receptors and BDNF.

                                           

Biography

2025 -  

Postdoctoral Researcher at the Neurobiology Research Unit

2022 - 2025 

PhD Student at the Lyon Neuroscience Researcher Center (CRNL), Université Claude Bernard Lyon 1 and Neurolixis SAS, France.

2020 - 2021

MSc in Medicinal Chemistry and Molecular Pharmacology, Université Paris Cité, France.

2014 - 2021

PharmD, Université Claude Bernard Lyon 1, France.

 

Publications

Richin V, Valdebenito M, Vidal B, Bouillot C, Bouvard S, Daligault S, Newman-Tancredi A, Zeinyeh W, Zimmer L. Multimodal neuroimaging for PK/PD profile of NLX-204, a biased 5-HT1A receptor agonist. ACS Chemical Neuroscience. 2025 Jul.16; 16(14): 2738-2746. DOI: 10.1021/acschemneuro.5c00342.

Richin V, Bouillot C, Bouvard S, Courault P, Lancelot S, Zimmer L, Zeinyeh W. [18F]RS-127445 Radiosynthesis and Evaluation as a 5-HT2B Receptor PET Radiotracer in Rat Brain. Bioorganic & Medicinal Chemistry Letters. 2024 Nov 1; 112:129933. DOI: 10.1016/j.bmcl.2024.129933

 

Awards

2025 - Travel award to attend the International Society for Serotonin Research (ISSR) meeting in Vienna, Austria.

2024 - Best Poster Award. 6th scientific days of the research network on molecular imaging agents (GDR AIM) in Lyon, France. Award sponsored by the European Society for Molecular Imaging (ESMI).